Inventor · disambiguated record
Mark Reynolds
Also filed as: REYNOLDS MARK · REYNOLDS MARK A · REYNOLDS MARK ALAN
32 granted patents·8 pending applications·3,456 citations·filing 1994–2023
98Inventor score
Top patents by PatentIndex Score
40 records- 0198US6673611B2Nucleic acid molecules with novel chemical compositions capable of modulating gene expressionSIRNA THERAPEUTICS INC·Filed 2001·Granted Jan 6, 2004·218 cites·17 claims
- 0298US5585481ALinking reagents for nucleotide probesGEN PROBE INC·Filed 1994·Granted Dec 17, 1996·1.4k cites·50 claims
- 0397US6395713B1Compositions for the delivery of negatively charged moleculesRIBOZYME PHARM INC·Filed 1998·Granted May 28, 2002·367 cites·13 claims
- 0497US5696251ANon-nucleotide linking reagents for nucleotide probesGEN PROBE INC·Filed 1995·Granted Dec 9, 1997·129 cites·49 claims
- 0596US6060456AChimeric oligonucleoside compoundsGENTA INC·Filed 1997·Granted May 9, 2000·218 cites·38 claims
- 0695US7553830B2Compositions for the delivery of negatively charged moleculesSIRNA THERAPEUTICS INC·Filed 2005·Granted Jun 30, 2009·20 cites·10 claims
- 0794US10137127B2Liquid formulations of (S)-N-(5-((R)-2-(2,5-difluorophenyl)-pyrrolidin-1-yl)-pyrazolo[1,5-A]pyrimidin-3-yl)-3-hydroxypyrrolidine-1-carboxamideLOXO ONCOLOGY INC·Filed 2017·Granted Nov 27, 2018·17 cites·30 claims
- 0893US6028188ASynthetic oligomers having chirally pure phosphonate internucleosidyl linkages mixed with non-phosphonate internucleosidyl linkagesGENTA INC·Filed 1994·Granted Feb 22, 2000·251 cites·23 claims
- 0993US5656744AMethods for making nucleotide polymers using novel linking reagentsGEN PROBE INC·Filed 1995·Granted Aug 12, 1997·155 cites·51 claims
- 1092US6262036B1Method for inhibiting RNA translation using chimeric oligonucleoside compoundsGENTA INC·Filed 2000·Granted Jul 17, 2001·41 cites·36 claims
- 1192US5599667APolycationic supports and nucleic acid purification separation and hybridizationGEN PROBE INC·Filed 1994·Granted Feb 4, 1997·221 cites·73 claims
- 1291US10786489B2Formulations of 6-(2-hydroxy-2-methylpropxy)-4-(6-(6-((6-methoxypyridin-3-yl)methyl)-3,6-diazabicyclo[3.1.1]heptan-3-yl)pyridin-3-yl)pyrazolo[1,5-A]pyridine-3-carbonitrileLOXO ONCOLOGY INC·Filed 2018·Granted Sep 29, 2020·9 cites·18 claims
- 1390US6031091ANon-nucleotide linking reagents for nucleotide probesGEN PROBE INC·Filed 1997·Granted Feb 29, 2000·130 cites·32 claims
- 1488US10668072B2Liquid formulations of (S)-N-(5-((R)-2-(2,5-difluorophenyl)-pyrrolidin-1-yl)-pyrazolo[1,5-a]pyrimidin-3-yl)-3-hydroxypyrrolidine-1-carboxamideLOXO ONCOLOGY INC·Filed 2018·Granted Jun 2, 2020·2 cites·22 claims
- 1588US8399222B2Compositions and methods for detecting small RNAs, and uses thereofSIVA AMARA·Filed 2009·Granted Mar 19, 2013·30 cites·45 claims
- 1688US6316608B1Combined polynucleotide sequence as discrete assay endpointsINCYTE GENOMICS INC·Filed 2000·Granted Nov 13, 2001·27 cites·15 claims
- 1785US9938590B2Capture probes immobilizable via L-nucleotide tailPOLLNER REINHOLD·Filed 2011·Granted Apr 10, 2018·5 cites·23 claims
- 1881US5986083ASynthetic oligomers having phosphonate internucleosidyl linkages of undefined chirality mixed with non-phosphonate internucleosidyl linkagesGENTA INC·Filed 1994·Granted Nov 16, 1999·46 cites·21 claims
- 1978US12138250B2Formulations of 6-(2-hydroxy-2-methylpropoxy)-4-(6-(6-((6-methoxypyridin-3-yl)methyl)-3,6-diazabicyclo[3.1.1]heptan-3-yl)pyridin-3-yl)pyrazolo[1,5-a]pyridine-3-carbonitrileLOXO ONCOLOGY INC·Filed 2022·Granted Nov 12, 2024·0 cites·13 claims
- 2077US11963950B2Formulations of 6-(2-hydroxy-2-methylpropoxy)-4-(6-(6-((6-methoxypyridin-3-yl)methyl)-3,6-diazabicyclo[3.1.1]heptan-3-yl)pyridin-3-yl)pyrazolo[1,5-a]pyridine-3-carbonitrileLOXO ONCOLOGY INC·Filed 2021·Granted Apr 23, 2024·0 cites·23 claims
- 2174US6380169B1Metal complex containing oligonucleoside cleavage compounds and therapiesISIS PHARMACEUTICALS INC·Filed 1994·Granted Apr 30, 2002·43 cites·14 claims
- 2273US2010036115A1Novel Compositions for the Delivery of Negatively Charged MoleculesSIRNA THERAPEUTICS INC·Filed 2009·Application pending·0 cites
- 2371US12102621B2Formulations of 6-(2-hydroxy-methylpropoxy-4-(6-(6-((6-methoxypyridin-3-yl)methyl)-3,6-diazabicyclo[3.1.1]heptan-3-yl)pyridin-3-yl)pyrazolo[1,5-a]pyridine-3-carbonitrileLOXO ONCOLOGY INC·Filed 2020·Granted Oct 1, 2024·0 cites·16 claims
- 2470US9267305B1Louvered snow plowREYNOLDS MARK A·Filed 2008·Granted Feb 23, 2016·7 cites·2 claims
- 2570US5854410AOligonucleoside cleavage compounds and therapiesGENTA INC·Filed 1994·Granted Dec 29, 1998·31 cites·2 claims
- 2668US11484535B2Liquid formulations of (S)-N-(5-((R)-2-(2,5-difluorophenyl)-pyrrolidin-1-yl)-pyrazolo[1,5-a] pyrimidin-3-yl)-3-hydroxypyrrolidine-1-carboxamideLOXO ONCOLOGY INC·Filed 2020·Granted Nov 1, 2022·0 cites·33 claims
- 2766US5837856AChirally enriched synthetic phosphonate oligomersGENTA INC·Filed 1997·Granted Nov 17, 1998·20 cites·22 claims
- 2865US5955597AChirally enriched synthetic phosphate oligomersGENTA INC·Filed 1997·Granted Sep 21, 1999·19 cites·20 claims
- 2963US5792615ASynthetic oligomers having chirally pure phoshonate internucleosidyl linkages mixed with non-phosphonate internucleosidyl linkagesGENTA INC·Filed 1997·Granted Aug 11, 1998·21 cites·20 claims
- 3062US11035012B2Capture probes immobilizable via L-nucleotide tailGEN PROBE INC·Filed 2018·Granted Jun 15, 2021·0 cites·19 claims
- 3162US2025099604A1Pharmaceutical compositions comprising anti-tissue factor antibody-drug conjugatesEXELIXIS INC·Filed 2023·Application pending·0 cites
- 3258US2005176018A1Chemically modified double stranded nucleic acid moleculesSIRNA THERAPEUTICS INC·Filed 2003·Application pending·0 cites
- 3357US8951730B2Compositions for detecting small RNAsGEN PROBE INC·Filed 2013·Granted Feb 10, 2015·0 cites·20 claims
- 3457US5811538AProcess for the purification of oligomersGENTA INC·Filed 1994·Granted Sep 22, 1998·20 cites·31 claims
- 3553US2002115093A1Combined polynucleotide sequences as discrete assay endpointsFiled 2001·Application pending·0 cites
- 3646US11214571B2Process for the preparation of (S)-N-(5-((R)-2-(2,5-difluorophenyl)pyrrolidin-1-yl)-pyrazolo[1,5-a]pyrimidin-3-yl)-3-hydroxypyrrolidine-1-carboxamide and salts thereofARRAY BIOPHARMA INC·Filed 2017·Granted Jan 4, 2022·0 cites·16 claims
- 3745US2003073640A1Novel compositions for the delivery of negatively charged moleculesRIBOZYME PHARM INC·Filed 2001·Application pending·0 cites
- 3843US2011135504A1Biological stimulant foaming applicationREYNOLDS MARK ALAN·Filed 2010·Application pending·0 cites
- 3942US2008032835A1Multiple Sprocket Chain Guide For Front Bicycle DerailleurREYNOLDS MARK A·Filed 2007·Application pending·0 cites
- 4029US2003035829A1Liposomal compositions for the delivery of nucleic acid catalystsTOWNSEND & TOWNSEND & CREW LLP·Filed 1998·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Mark Reynolds files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →